Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery Disease

Stopped discontinued due to change in operating plans prior to study initiation and enrollment

Conditions

• Peripheral Artery Disease
• Peripheral Arterial Disease

Interventions

• DRUG: Sapropterin Dihydrochloride (BH4, tetrahydrobiopterin)
• DRUG: Placebo

Sponsor

University of Nebraska